Lin An
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Inflammasome and immune disorders 3
- Gut microbiota and health 2
- Co-authors
- Jun Chen (3 shared papers)Weiwei Tang (2 shared papers)Liying Peng (1 shared paper)Xiaowei Zhang (1 shared paper)Ping Zhang (1 shared paper)Ningyuan Sun (1 shared paper)Dingyuan Ma (1 shared paper)Lingling Dai (7 shared papers)
- Journals
- Chinese Chemical Letters (3 papers)International Journal of Gynecological Cancer (2 papers)International Journal of Cardiology (2 papers)Journal of Clinical Oncology (2 papers)Cardiovascular Research (2 papers)
- Partner nations
- ChinaUnited StatesSri Lanka
In The Last Decade
Lin An
51 papers receiving 713 citations
Peers
Comparison fields: 5 of 87
- Nephrology 44
- Cancer Research 85
- Immunology 112
- Molecular Biology 344
- Physiology 21
Countries citing papers authored by Lin An
This map shows the geographic impact of Lin An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin An more than expected).
Fields of papers citing papers by Lin An
This network shows the impact of papers produced by Lin An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin An. The network helps show where Lin An may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 199 | |
| 2 | 2018 | 79 | |
| 3 | 2020 | 51 | |
| 4 | 2019 | 48 | |
| 5 | 2017 | 31 | |
| 6 | 2013 | 27 | |
| 7 | 2020 | 26 | |
| 8 | 2017 | 24 | |
| 9 | 2018 | 24 | |
| 10 | 2019 | 20 | |
| 11 | 2017 | 18 | |
| 12 | 2023 | 14 | |
| 13 | 2022 | 11 | |
| 14 | 2024 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 9 | |
| 17 | 2024 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2020 | 8 | |
| 20 | Familial lichen planus. | 1986 | 7 |
About Lin An
Lin An is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Organic Chemistry, having authored 55 papers that have together received 721 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Autoimmune Bullous Skin Diseases (3 papers), Inflammasome and immune disorders (3 papers), Autophagy in Disease and Therapy (3 papers), Skin and Cellular Biology Research (3 papers), PARP inhibition in cancer therapy (3 papers), Gut microbiota and health (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). The work is most often cited by research in Nephrology (44 citations), Cancer Research (85 citations), Immunology (112 citations), Molecular Biology (344 citations) and Physiology (21 citations). Lin An has collaborated with scholars based in China, United States and Sri Lanka. Frequent co-authors include Jun Chen, Weiwei Tang, Liying Peng, Xiaowei Zhang, Ping Zhang, Ningyuan Sun, Dingyuan Ma, Lingling Dai, Xi Wang and Zhe Cheng. Their work appears in journals such as Chinese Chemical Letters, International Journal of Gynecological Cancer, International Journal of Cardiology, Journal of Clinical Oncology and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.